Matches in Wikidata for { <http://www.wikidata.org/entity/Q84217609> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q84217609 description "artikull shkencor i botuar më 01 janar 2012" @default.
- Q84217609 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q84217609 description "im Jahr 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84217609 description "scientific article published on 01 January 2012" @default.
- Q84217609 description "wetenschappelijk artikel" @default.
- Q84217609 description "наукова стаття, опублікована в січні 2012" @default.
- Q84217609 description "научна статия" @default.
- Q84217609 name "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 name "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 name "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 type Item @default.
- Q84217609 label "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 label "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 label "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 prefLabel "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 prefLabel "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 prefLabel "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 P1433 Q84217609-27E7D2B6-F92D-4CC8-A70D-C14DC1CA9BD9 @default.
- Q84217609 P1476 Q84217609-DD761CCA-49BA-4646-9BE5-4AF054DBF1F1 @default.
- Q84217609 P2093 Q84217609-13E10025-C313-451A-B91F-E43A2E417A4D @default.
- Q84217609 P2093 Q84217609-5070B833-D1C7-483A-8CC1-9313499AAFDE @default.
- Q84217609 P2093 Q84217609-C380D2A4-424F-4D13-A930-FC0CD73F5E15 @default.
- Q84217609 P2093 Q84217609-D092DD03-DB8C-4FC7-BBA4-363B334221E0 @default.
- Q84217609 P304 Q84217609-E0069BCD-156E-4FE4-9226-9EE7F2938BFB @default.
- Q84217609 P31 Q84217609-13BEF697-BEF2-4C02-A869-23B1B28C4AD6 @default.
- Q84217609 P433 Q84217609-85A58728-5C6E-4DCD-A72E-F49A5B015E0C @default.
- Q84217609 P478 Q84217609-846D9476-1695-4264-B5CF-96F290A8B560 @default.
- Q84217609 P577 Q84217609-668F354D-469C-40B6-8BCF-4CA1BD491F69 @default.
- Q84217609 P698 Q84217609-F69B5826-666B-4A4A-A75D-6ADBA176D4F6 @default.
- Q84217609 P921 Q84217609-C1DBA31A-D361-4372-952F-4262E267D3C2 @default.
- Q84217609 P698 22629839 @default.
- Q84217609 P1433 Q27713832 @default.
- Q84217609 P1476 "[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]" @default.
- Q84217609 P2093 "Cherenkov VG" @default.
- Q84217609 P2093 "Petrov AB" @default.
- Q84217609 P2093 "Shpenkova AA" @default.
- Q84217609 P2093 "Vasil'eva TM" @default.
- Q84217609 P304 "110-114" @default.
- Q84217609 P31 Q13442814 @default.
- Q84217609 P433 "1" @default.
- Q84217609 P478 "58" @default.
- Q84217609 P577 "2012-01-01T00:00:00Z" @default.
- Q84217609 P698 "22629839" @default.
- Q84217609 P921 Q172341 @default.